A securities fraud class action has been filed against Ardent Health Inc. and certain senior executives in the U.S. District Court for the Middle District of Tennessee. The suit alleges the company misrepresented how it assessed the collectability of accounts receivable, inflating reported receivables and delaying recognition of uncollectable accounts. The litigation follows a sharp share-price drop after Ardent disclosed a $43 million revenue decrease tied to revised collection-trend evaluations and a $54 million increase in professional liability reserves. Investors have until March 9, 2026 to seek appointment as lead plaintiff.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202602180646NEWSFILECNPR____20260218_284175_1) on February 18, 2026, and is solely responsible for the information contained therein.